ERNAW
Ernexa Therapeutics Inc.Warrants of Ernexa Therapeutics Inc. · ERNA stock page →
—
Market cap
$36.1K
Nano cap
1 year
−93.5%
from $29.75 · Oct 27
30 days
−44.1%
from $3.47
52-week range
$1.94–47.00
at the low
Avg volume 20D
71.3K
Oct 7 spike 662.9K
Short interest
🔒 Subscribers only
Filing reports
1
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- R Mar 31 Ernexa Therapeutics' S-3 shelf registration has become effective, al…
- X Sep 15 Short interest jumps 169.2% to 1.9K
Signal stack
Where each data set points today.
- TrendDOWNTREND
44% below its 50-day average. New closing low $1.94 on Oct 26.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| Clear Street Group Inc. | 149,499 | $10.7K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 57,890 | $4.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
SecBot reports
1 filing · 0 bullish · 1 bearishAll ERNAW filing & press-release reports (1)
- EFFECT reportMar 31, 2026